NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood.

Author(s): Amoli MM, Carthy D, Platt H, Ollier WE

Publication: Int J Epidemiol, 2008, Vol. 37 Suppl 1, Page i41-5

PubMed ID: 18381392 PubMed Review Paper? No

Suggested by: ISBER


Purpose of Paper

The purpose of this paper was to assess the viability, purity, and transformability of B lymphocytes obtained from cryopreserved whole blood held at room temperature for approximately 1 day prior to cryopreservation.

Conclusion of Paper

Thawing of 10 whole blood specimens that had been cryopreserved without a delay at room temperature revealed significant haemolysis. The B lymphocytes obtained by magnetic-activated cell sorting were >95% pure by flow cytometry and 70-75% appeared viable by phase contrast microscopy. All 10 specimens were subsequently Epstein Barr Virus (EBV) immortalized. A delay at room temperature of approximately 1 day prior to cryopreservation of blood specimens resulted in 92.5% EBV transformability. The nontransformable specimens consisted of one specimen with a fungal contamination and two others with bacterial contamination.

Studies

  1. Study Purpose

    The purpose of this study was to assess the viability, purity, and transformability of B lymphocytes obtained from cryopreserved whole blood held at room temperature for approximately 1 day prior to cryopreservation.

    Summary of Findings:

    Thawing of 10 whole blood specimens that had been cryopreserved without a delay at room temperature revealed significant haemolysis. The B lymphocytes obtained by magnetic-activated cell sorting were >95% pure by flow cytometry and 70-75% appeared viable by phase contrast microscopy. All 10 specimens were subsequently EBV immortalized. A delay at room temperature of approximately 1 day prior to cryopreservation of blood specimens resulted in 92.5% EBV transformability. The nontransformed specimens consisted of one specimen with fungal contamination and two others with bacterial contamination.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Cell count/volume Flow cytometry
    Cell count/volume Magnetic-activated cell sorting
    Morphology Macroscopic observation
    Morphology Colorimetric assay
    Morphology Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Time at room temperature 0 d
    1 d
    Storage Storage temperature -150 degrees C
    Biospecimen Acquisition Anticoagulant Acid-citrate-dextrose

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...